Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis
Open Access
- 27 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-11
- https://doi.org/10.1038/s41598-021-81752-0
Abstract
Crimean–Congo hemorrhagic fever virus (CCHFV) causes a zoonotic disease, Crimean–Congo hemorrhagic fever (CCHF) endemic in Africa, Asia, the Middle East, and Southeastern Europe. However, the prevalence of CCHF is not monitored in most of the endemic countries due to limited availability of diagnostic assays and biosafety regulations required for handling infectious CCHFV. In this study, we established a protocol to purify the recombinant CCHFV nucleoprotein (NP), which is antigenically highly conserved among multiple lineages/clades of CCHFVs and investigated its utility in an enzyme-linked immunosorbent assay (ELISA) to detect CCHFV-specific antibodies. The NP gene was cloned into the pCAGGS mammalian expression plasmid and human embryonic kidney 293 T cells were transfected with the plasmid. The expressed NP molecule was purified from the cell lysate using cesium-chloride gradient centrifugation. Purified NP was used as the antigen for the ELISA to detect anti-CCHFV IgG. Using the CCHFV NP-based ELISA, we efficiently detected CCHFV-specific IgG in anti-NP rabbit antiserum and CCHFV-infected monkey serum. When compared to the commercially available Blackbox CCHFV IgG ELISA kit, our assay showed equivalent performance in detecting CCHFV-specific IgG in human sera. These results demonstrate the usefulness of our CCHFV NP-based ELISA for seroepidemiological studies.Funding Information
- Ministry of Health, Labour and Welfare (H29-Sinkogyousei-Shitei-002)
- Japan Agency for Medical Research and Development (JP19fm0208101, JP19fm0208101)
- National Institutes of Health
- Science and Technology Research Partnership for Sustainable Development (JP18jm0110019)
This publication has 45 references indexed in Scilit:
- Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approachJournal of Virological Methods, 2013
- Migratory Birds, Ticks, and Crimean-Congo Hemorrhagic Fever VirusEmerging Infectious Diseases, 2012
- Diagnostic Assays for Crimean-Congo Hemorrhagic FeverEmerging Infectious Diseases, 2012
- Structure of Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein: Superhelical Homo-Oligomers and the Role of Caspase-3 CleavageJournal of Virology, 2012
- Chimeric protein A/G conjugate for detection of anti–Toxoplasma gondiiimmunoglobulin G in multiple animal speciesJournal of Veterinary Diagnostic Investigation, 2012
- Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomographyProceedings of the National Academy of Sciences of the United States of America, 2012
- Inhibition of Interferon Induction and Action by the Nairovirus Nairobi Sheep Disease Virus/Ganjam VirusPLOS ONE, 2011
- Evaluation of a Crimean-Congo hemorrhagic fever virus recombinant antigen expressed by Semliki Forest suicide virus for IgM and IgG antibody detection in human and animal sera collected in IranJournal of Clinical Virology, 2006
- Co-evolutionary patterns of variation in small and large RNA segments of Crimean-Congo hemorrhagic fever virusJournal of General Virology, 2005
- Recombinant nucleoprotein‐based serological diagnosis of Crimean–Congo hemorrhagic fever virus infectionsJournal of Medical Virology, 2004